GSK Performance & Benchmarks - -1.1% in 12m
The Total Return for 3m is -2%, for 6m 10.1% and YTD 13.6%. Compare with Peer-Group: Pharmaceuticals
Performance Rating
42.39%
#21 in Peer-Group
Rel. Strength
40.98%
#4537 in Stock-Universe
Total Return 12m
-1.07%
#76 in Peer-Group
Total Return 5y
42.99%
#38 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 17.6 |
| P/E Forward | 8.89 |
| High / Low | USD |
|---|---|
| 52 Week High | 42.79 USD |
| 52 Week Low | 31.37 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 46.40 |
| Buy/Sell Signal +-5 | 0.37 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: GSK (-1.1%) vs XLV (-11.8%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Short Term Performance
| Symbol | 1w | 1m | 3m |
|---|---|---|---|
| GSK | -1.08% | -3.57% | -1.95% |
| SCLX | 12.1% | 122% | 163% |
| NMRA | -33.6% | 96.0% | 102% |
| KALA | -7.29% | 55.0% | 102% |
Long Term Performance
| Symbol | 6m | 12m | 5y |
|---|---|---|---|
| GSK | 10.1% | -1.07% | 43% |
| VRNA | 78.3% | 365% | 1,479% |
| AMLX | 126% | 273% | -57.3% |
| ALTS | 3.80% | 303% | 48.8% |
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-0.45% | 81.9% | 350% | 58.4 | 54.6 | 0.61 | 32.2% | -1.12% |
| NVS NYSE Novartis |
-6.34% | 6.56% | 78.4% | 17.1 | 13.3 | 1.28 | 58.9% | - |
| LLY NYSE Eli Lilly |
-1.75% | -7.8% | 429% | 65.5 | 36.6 | 1.23 | 61.9% | 42.8% |
| NOVN SW Novartis |
-3.79% | 0.98% | 56.8% | 17.3 | 13.3 | 1.27 | 63.7% | 33.2% |
| GSK NYSE GlaxoSmithKline |
-3.57% | -1.07% | 43% | 17.6 | 8.89 | 0.39 | -13.7% | 23.9% |
| AZN NASDAQ AstraZeneca |
3.48% | -7.09% | 46% | 28.9 | 16 | 0.96 | 61.2% | 98.6% |
| SOBI ST Swedish Orphan Biovitrum |
-7.29% | -4.89% | 47.4% | 22.3 | 20 | 1.84 | 19.8% | 42.6% |
| ZEG XETRA AstraZeneca |
6.04% | -12.4% | 45.7% | 29 | 16.7 | 1 | 60.5% | 101% |
Performance Comparison: GSK vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for GSK
| Total Return (including Dividends) | GSK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -3.57% | -4.08% | 0.66% |
| 3 Months | -1.95% | -3.57% | 11.66% |
| 12 Months | -1.07% | -11.78% | 15.92% |
| 5 Years | 42.99% | 33.11% | 103.09% |
| Trend Stabilty (consistency of price movement) | GSK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -45% | -29.7% | 66.4% |
| 3 Months | -10.1% | 25% | 96.6% |
| 12 Months | 1.6% | -83% | 50% |
| 5 Years | 90.1% | 86.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | 33 %th | 0.53% | -4.20% |
| 3 Month | 36 %th | 1.68% | -12.19% |
| 12 Month | 62 %th | 12.13% | -14.66% |
| 5 Years | 82 %th | 7.42% | -29.59% |
FAQs
Does GlaxoSmithKline (GSK) outperform the market?
Yes,
over the last 12 months GSK made -1.07%, while its related Sector, the Health Care Sector SPDR (XLV) made -11.78%.
Over the last 3 months GSK made -1.95%, while XLV made -3.57%.
Performance Comparison GSK vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GSK vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.3% | -4.2% | 5.4% | -17% |
| US NASDAQ 100 | QQQ | 1.1% | -4.8% | 2.9% | -22% |
| German DAX 40 | DAX | 2.2% | -2.5% | 1.2% | -30% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.5% | -6.3% | 1.1% | -23% |
| Hongkong Hang Seng | HSI | 1.1% | -5.7% | -17.3% | -40% |
| India NIFTY 50 | INDA | 0.9% | 2% | 6.5% | 5% |
| Brasil Bovespa | EWZ | 0% | 3.9% | 3.1% | -5% |
GSK vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.3% | -2.1% | 6.1% | -26% |
| Consumer Discretionary | XLY | 2.8% | -2.6% | 15.3% | -20% |
| Consumer Staples | XLP | 0.6% | -1.4% | 7.7% | -6% |
| Energy | XLE | 0.7% | -3.7% | 11.5% | 1% |
| Financial | XLF | 2.7% | -1.2% | 9.1% | -22% |
| Health Care | XLV | 2.8% | 0.5% | 20.4% | 11% |
| Industrial | XLI | 2.3% | -4.7% | 0.1% | -22% |
| Materials | XLB | 5% | 0.2% | 11.5% | 3% |
| Real Estate | XLRE | 2.4% | -2.6% | 8.7% | -3% |
| Technology | XLK | 0.8% | -6% | -3.2% | -24% |
| Utilities | XLU | -2.6% | -8.3% | -1.1% | -20% |
| Aerospace & Defense | XAR | 1.7% | -7.7% | -12.7% | -47% |
| Biotech | XBI | 0.8% | -7% | 16.1% | 12% |
| Homebuilder | XHB | 1.4% | -4.7% | 11.3% | 7% |
| Retail | XRT | 3.7% | -1.6% | 10.8% | -4% |
GSK vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -4.6% | -8.34% | 10.5% | -3% |
| Natural Gas | UNG | 0.4% | 6.3% | 32.9% | -5% |
| Gold | GLD | -1.6% | -4.1% | -8.9% | -38% |
| Silver | SLV | 2% | -6.2% | -7.1% | -30% |
| Copper | CPER | 22% | 9.1% | 8.6% | -9% |
GSK vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.7% | -3.2% | 8.7% | 3% |
| iShares High Yield Corp. Bond | HYG | -0.5% | -3.3% | 6.7% | -9% |